Quantum Biopharma (QNTM) Change in Account Payables (2019 - 2026)

Quantum Biopharma has disclosed Change in Account Payables across 8 years of filings, most recently posting -$3.3 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at -$3.3 million, down 238.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 159.42% YoY), and the FY2025 annual result was $4.2 million, down 2.07% from the prior year.
• Change in Account Payables came in at -$3.3 million for Q1 2026 at Quantum Biopharma, down from -$214343.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.7 million in Q2 2022 to a low of -$3.3 million in Q1 2026.
• The 5-year median for Change in Account Payables is $3.1 million (2024), against an average of $2.4 million.
• Peak annual rise in Change in Account Payables reached 443.46% in 2024, while the deepest fall reached 271.81% in 2024.
• Quantum Biopharma's Change in Account Payables stood at $723769.0 in 2022, then retreated by 20.54% to $575080.0 in 2023, then surged by 443.46% to $3.1 million in 2024, then slumped by 106.86% to -$214343.0 in 2025, then sank by 1421.9% to -$3.3 million in 2026.
• The last three Change in Account Payables figures came in at -$3.3 million (Q1 2026), -$214343.0 (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.